Physician profile
Douglas Lowery
NPI 1609819168
$2,530.63
in general payments reported to CMS, 2019-2025
13 companies · $1,008 in 2025
The $1,008 reported for 2025 was more than what 79% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.42 · 2020: $62.84 · 2021: $268 · 2022: $441 · 2023: $250 · 2024: $475 · 2025: $1,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,600 · Education: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,599.55 |
| Education | $132.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $519.03 | 2020-2025 | |
| Glaxosmithkline, LLC. | $513.67 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $466.56 | 2020-2025 | Dupixent |
| Genzyme Corporation | $430.59 | 2021-2025 | |
| Inspire Medical Systems, INC. | $222.89 | 2022-2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $98.99 | 2025 | |
| Smith+Nephew, INC. | $76.29 | 2024 | Halo, Coblation, Ent Sinus |
| Amgen INC. | $58.67 | 2025 | Tezspire |
| Intersect Ent, INC. | $50.10 | 2019-2020 | |
| Med-El Corporation | $31.42 | 2024 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit |
| Advanced Bionics, LLC | $27.26 | 2022 | |
| Alk-Abello, INC | $18.17 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.99 | 2025 | Xhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Lowery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.